• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国神木市成年居民血脂异常患病率及相关危险因素分析。

Prevalence of dyslipidemia and associated risk factors among adult residents of Shenmu City, China.

机构信息

Shenmu Hospital Affiliated to Northwest University, Shenmu City Hospital, Shenmu, Shaanxi province, China.

Institute of Basic Medicine, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

PLoS One. 2021 May 7;16(5):e0250573. doi: 10.1371/journal.pone.0250573. eCollection 2021.

DOI:10.1371/journal.pone.0250573
PMID:33961634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8104371/
Abstract

OBJECTIVE

Dyslipidemia is a leading risk factor for cardiovascular and cerebrovascular diseases. By collecting the blood lipid profiles among adult residents of Shenmu City in Shaanxi Province, China, we aim to assess and elucidate the prevalence and risk factors of dyslipidemia in this city.

METHOD

Stratified multistage sampling was used to survey 4,598 permanent adult residents in five areas of Shenmu (2 communities in the county seat, 2 in the southern area and 2 in the northern area) from September 2019 to December 2019. Questionnaire surveys and physical examinations were conducted. Data were analyzed using SPSS software version 26.0.

RESULTS

The average level of total cholesterol (TC) is 4.47mmol/L, that of triglyceride (TG) 1.32mmol/L, high-density lipoprotein cholesterol (HDL-C) 1.27mmol/L, apolipoprotein A1 (ApoA1) 1.44g/L, low-density lipoprotein cholesterol (LDL-C) 2.7mmol/L and apolipoprotein B (ApoB) 0.97g/L. The prevalence of hypercholesterolemia (HTC), hypertriglyceridemia (HTG), low high-density lipoprotein (HDL-C) and high low-density lipoprotein (LDL-C) is 22.4%, 33.3%, 14.5%, and 5.81%, respectively, and the overall prevalence of dyslipidemia is 48.27%. Furthermore, blood lipid levels and prevalence of dyslipidemia vary by region, age, gender, occupation and educational level. Nine risk factors of dyslipidemia were identified, which are living in county seat or northern industrial area, increasing age, male, overweight or obesity, abdominal obesity, smoking, hypertension, abnormal glucose metabolism (pre-diabetes or diabetes) and hyperuricemia.

CONCLUSION

The blood lipid levels and dyslipidemia prevalence of adults in Shenmu City are higher comparing to national averages of China. Combining risk factors of dyslipidemia, early detection and public health interventions are necessary in high-risk population for associated cardiovascular and cerebrovascular diseases prevention.

摘要

目的

血脂异常是心脑血管疾病的主要危险因素。本研究通过收集陕西省神木市成年居民的血脂谱数据,旨在评估和阐明该市血脂异常的患病率和危险因素。

方法

采用分层多阶段抽样方法,于 2019 年 9 月至 12 月调查了神木市五个地区(县城 2 个社区、南部 2 个地区和北部 2 个地区)的 4598 名常住成年居民。进行问卷调查和体格检查。使用 SPSS 软件版本 26.0 分析数据。

结果

总胆固醇(TC)平均水平为 4.47mmol/L,三酰甘油(TG)为 1.32mmol/L,高密度脂蛋白胆固醇(HDL-C)为 1.27mmol/L,载脂蛋白 A1(ApoA1)为 1.44g/L,低密度脂蛋白胆固醇(LDL-C)为 2.7mmol/L,载脂蛋白 B(ApoB)为 0.97g/L。高胆固醇血症(HTC)、高甘油三酯血症(HTG)、低高密度脂蛋白(HDL-C)和高低密度脂蛋白(LDL-C)的患病率分别为 22.4%、33.3%、14.5%和 5.81%,血脂异常的总患病率为 48.27%。此外,血脂水平和血脂异常的患病率因地区、年龄、性别、职业和教育水平而异。确定了血脂异常的 9 个危险因素,包括居住在县城或北部工业区、年龄增长、男性、超重或肥胖、腹型肥胖、吸烟、高血压、葡萄糖代谢异常(糖尿病前期或糖尿病)和高尿酸血症。

结论

与中国全国平均水平相比,神木市成年人的血脂水平和血脂异常患病率较高。结合血脂异常的危险因素,对高危人群进行早期检测和公共卫生干预,对于预防相关心脑血管疾病是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da5/8104371/05723d13e797/pone.0250573.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da5/8104371/0d3eed06e0ba/pone.0250573.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da5/8104371/05723d13e797/pone.0250573.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da5/8104371/0d3eed06e0ba/pone.0250573.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da5/8104371/05723d13e797/pone.0250573.g002.jpg

相似文献

1
Prevalence of dyslipidemia and associated risk factors among adult residents of Shenmu City, China.中国神木市成年居民血脂异常患病率及相关危险因素分析。
PLoS One. 2021 May 7;16(5):e0250573. doi: 10.1371/journal.pone.0250573. eCollection 2021.
2
[Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].[吉林省社区糖尿病患者血脂异常情况分析]
Wei Sheng Yan Jiu. 2014 Sep;43(5):743-8.
3
The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey.中国东北地区血脂异常的患病率、知晓率、治疗率及控制率:一项基于人群的横断面调查。
Lipids Health Dis. 2017 Mar 23;16(1):61. doi: 10.1186/s12944-017-0453-2.
4
Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.土耳其成年人血脂异常及相关危险因素的患病率:特拉布宗血脂研究
Endocrine. 2008 Aug-Dec;34(1-3):36-51. doi: 10.1007/s12020-008-9100-z. Epub 2008 Nov 12.
5
[Current status of blood lipids in people with hypertension and diabetes in Henan province].[河南省高血压合并糖尿病患者的血脂现状]
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 May 24;47(5):360-366. doi: 10.3760/cma.j.issn.0253-3758.2019.05.006.
6
Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP).中国农村和城市成年人血脂异常的患病率及相关危险因素:来自中国国家卒中筛查与防治项目(CNSSPP)的结果。
BMC Public Health. 2019 Nov 11;19(1):1500. doi: 10.1186/s12889-019-7827-5.
7
[Prevalence of dyslipidemia and normal blood lipids level in Uygur population in Kashgar area of Xinjiang Uygur Autonomous Region].[新疆维吾尔自治区喀什地区维吾尔族人群血脂异常及血脂正常水平的患病率]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Jun 10;38(6):702-708. doi: 10.3760/cma.j.issn.0254-6450.2017.06.003.
8
[Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].[新疆阜康市30岁以上哈萨克族人群血脂水平及相关因素的流行病学调查]
Zhonghua Yu Fang Yi Xue Za Zhi. 2011 May;45(5):440-3.
9
Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults.中国成年人血脂异常患病率及低密度脂蛋白胆固醇达标率:一项全国代表性的 163641 名成年人调查。
Int J Cardiol. 2018 Jun 1;260:196-203. doi: 10.1016/j.ijcard.2017.12.069.
10
[Prevalence of dyslipidemia among residents aged 18-69 years in Shandong province of China, 2011].[2011年中国山东省18 - 69岁居民血脂异常患病率]
Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Mar;50(3):230-4. doi: 10.3760/cma.j.issn.0253-9624.2016.03.008.

引用本文的文献

1
National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022.2005年至2022年韩国血脂异常患病率、知晓率、治疗率和控制率的全国趋势。
Sci Rep. 2025 May 9;15(1):16148. doi: 10.1038/s41598-025-00354-2.
2
Exploring the Incidence and Risk Factors of Dyslipidemia in Patients with Severe Acne Vulgaris on Systemic Isotretinoin Therapy: Findings from a Prospective Study.探索重度寻常痤疮患者接受系统性异维甲酸治疗时血脂异常的发生率及危险因素:一项前瞻性研究的结果
Medicina (Kaunas). 2025 Feb 28;61(3):439. doi: 10.3390/medicina61030439.
3
Evaluation of dyslipidemia based on ATP III guideline in adults in Southwest Iran: a population-based study.

本文引用的文献

1
Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia.埃塞俄比亚北部默克莱市成年居民血脂异常及相关危险因素的患病率
PLoS One. 2021 Feb 9;16(2):e0243103. doi: 10.1371/journal.pone.0243103. eCollection 2021.
2
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
3
Body mass index and risk of all-cause mortality with normoglycemia, impaired fasting glucose and prevalent diabetes: results from the Rural Chinese Cohort Study.
基于ATP III指南对伊朗西南部成年人血脂异常的评估:一项基于人群的研究。
Sci Rep. 2025 Mar 19;15(1):9463. doi: 10.1038/s41598-025-90141-w.
4
Prevalence and Characteristics of Dyslipidemia in a Hospital in Madagascar.马达加斯加一家医院血脂异常的患病率及特征
Cureus. 2024 Nov 11;16(11):e73424. doi: 10.7759/cureus.73424. eCollection 2024 Nov.
5
Overview of dyslipidemia and metabolic syndrome in myeloproliferative neoplasms.骨髓增殖性肿瘤中的血脂异常与代谢综合征概述
World J Clin Oncol. 2024 Jun 24;15(6):717-729. doi: 10.5306/wjco.v15.i6.717.
6
Causal effect of severe and non-severe malaria on dyslipidemia in African Ancestry individuals: A Mendelian randomization study.严重和非严重疟疾对非洲裔个体血脂异常的因果效应:一项孟德尔随机化研究。
Ann Hum Genet. 2025 Jul;89(4):178-187. doi: 10.1111/ahg.12555. Epub 2024 Mar 15.
7
Hyperuricemia and associated factors: The case of outpatients at the Bafoussam Regional Hospital- Cameroon, an analytical cross-sectional study.高尿酸血症及其相关因素:喀麦隆巴富萨姆地区医院门诊患者情况,一项分析性横断面研究。
Health Sci Rep. 2024 Feb 14;7(2):e1891. doi: 10.1002/hsr2.1891. eCollection 2024 Feb.
8
Lipid Profile and the Frequency of Dyslipidemia in Iranian Adolescents with Severe Obesity, Who Were Candidates for Bariatric Surgery.脂质谱与伊朗严重肥胖青少年接受减重手术候选人的血脂异常频率。
Obes Surg. 2024 Feb;34(2):618-624. doi: 10.1007/s11695-023-07038-8. Epub 2024 Jan 8.
9
Identifying Factors Related to Serum Lipids Using Multilevel Quantile Model: Analysis of Nationwide STEPs Survey 2016.使用多水平分位数模型识别与血脂相关的因素:2016年全国性 STEPs 调查分析
Int J Prev Med. 2023 May 27;14:69. doi: 10.4103/ijpvm.ijpvm_464_21. eCollection 2023.
10
The Association Between Chronological Age and Dyslipidemia: A Cross-Sectional Study in Chinese Aged Population.年龄与血脂异常的关系:中国老年人群的横断面研究。
Clin Interv Aging. 2023 Apr 20;18:667-675. doi: 10.2147/CIA.S406237. eCollection 2023.
体重指数与血糖正常、空腹血糖受损和现患糖尿病患者全因死亡率的关系:来自中国农村队列研究的结果。
J Epidemiol Community Health. 2018 Nov;72(11):1052-1058. doi: 10.1136/jech-2017-210277. Epub 2018 Jul 24.
4
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.2016年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南。
Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):115. doi: 10.1016/j.rec.2017.01.002.
5
Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.血浆脂质水平升高会加重 Duchenne 型肌营养不良症 mdx 小鼠模型中的肌肉病理学。
Skelet Muscle. 2017 Sep 12;7(1):19. doi: 10.1186/s13395-017-0135-9.
6
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.1990年至2015年全球、区域和国家10种心血管疾病病因负担
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25. doi: 10.1016/j.jacc.2017.04.052. Epub 2017 May 17.
7
Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia.营养保健品作为血脂异常联合治疗的重要组成部分。
Curr Pharm Des. 2017;23(17):2496-2503. doi: 10.2174/1381612823666170317145851.
8
PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.2016年家庭医生血脂异常管理的PoLA/CFPiP/PCS指南
Arch Med Sci. 2017 Feb 1;13(1):1-45. doi: 10.5114/aoms.2017.64712. Epub 2016 Dec 19.
9
American Diabetes Association Standards of Medical Care in Diabetes 2017.《2017年美国糖尿病协会糖尿病医疗护理标准》
J Diabetes. 2017 Apr;9(4):320-324. doi: 10.1111/1753-0407.12524.
10
Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study.中国早发与晚发 2 型糖尿病患者非致死性心血管疾病发病风险的比较:一项横断面研究。
Lancet Diabetes Endocrinol. 2016 Feb;4(2):115-24. doi: 10.1016/S2213-8587(15)00508-2. Epub 2015 Dec 17.